Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by OLIVARESRommy Morales of OLIVARES explains the key elements to consider for submitting post-filing experimental evidence -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law considers the use of a re-filing strategy against non-use cancellation
-
Sponsored by RNA, Technology and IP AttorneysRachna Bakhru of RNA Technology and IP Attorneys examines the law surrounding the ‘right to publicity’ in relation to the Olympics
-
Sponsored by Tilleke & GibbinsKhin Myo Myo Aye of Tilleke & Gibbins describes how the extension of the TRIPS transition period for least developed countries will impact companies operating in Myanmar
-
Sponsored by Patrinos & KilimirisEvangelia Sioumala of Patrinos & Kilimiris looks at a recent judgment from the Athens Administrative Court of First Instance that compared conceptually and visually similar images
-
Sponsored by AJ ParkAJ Park explores a recent case which emphasises the importance of submitting reliable evidence in invalidation proceedings, even where proceedings are undefended
